David Stanley Duch

Title: David Stanley Duch: Innovator in Antifolate Research

Introduction

David Stanley Duch is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifolate compounds. With a total of 7 patents to his name, Duch's work has had a considerable impact on reducing side effects associated with certain medications.

Latest Patents

Duch's latest patents focus on the combination of benzoquinazoline antifolates and protecting agents. These patents disclose the use of a protecting agent, such as a folate derivative like folic acid or leucovorin, in conjunction with a non-competitive folic acid analogue, specifically benzoquinazoline derivatives. This innovative approach aims to reduce the side effects associated with the administration of these non-competitive folic acid analogues, along with pharmaceutical formulations that comprise such combinations.

Career Highlights

Throughout his career, David Stanley Duch has worked with prominent companies in the pharmaceutical industry, including Burroughs Wellcome Co. and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Duch has collaborated with notable individuals in his field, including Charles A. Nichol and Carl W. Sigel. These partnerships have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

David Stanley Duch is a distinguished inventor whose work in antifolate research has led to significant advancements in pharmaceutical formulations. His contributions continue to influence the industry and improve patient outcomes.